Extended Data Fig. 4: Caspase‑3 immunohistochemical staining in tumor tissues from γδ CCR5KI CAR19 and γδ mock T cell treated mice. | Nature Biomedical Engineering

Extended Data Fig. 4: Caspase‑3 immunohistochemical staining in tumor tissues from γδ CCR5KI CAR19 and γδ mock T cell treated mice.

From: CCR5-targeted allogeneic gamma–delta CD19 chimeric antigen receptor T cells for HIV-associated B cell-malignancy immunotherapy

Extended Data Fig. 4: Caspase‑3 immunohistochemical staining in tumor tissues from γδ CCR5KI CAR19 and γδ mock T cell treated mice.The alternative text for this image may have been generated using AI.

Immunohistochemical (IHC) staining for caspase-3 (indicated by red arrows) in two different representative tissue sections of tumors treated with γδ CCR5KI-CAR19 (Tumor samples; CAM-19 and CAM-24) and γδ mock (samples; CAM-74 and CAM-35) T cells are shown. Tumors samples were taken from the experiment shown in Fig. 5a-e at termination. Scale bars are indicated.

Back to article page